Leinco Technologies

410 Arminister Dr
Fenton,  MO  63026

United States
  • Booth: 3747


Leinco Technologies is a contract manufacturer for the diagnostics & life science research industries. Our focus is on manufacturing of monoclonal antibodies & recombinant proteins, but we develop assay's for ELISA, Luminex, and lateral flow too. We also manufacture second step reagents like Steptavidin, Normal Serums, and IgG's plus have a 10,000+ catalog items full of related reagents for many different applications including Western Blot, ELISA, Flow Cytometry, IHC and much more.

 Press Releases

  • Leinco Technologies, Inc.  enters Agreement with Stage I Diagnostics to be their exclusive business development agent and assay development partner for novel oncology protein biomarkers

    Novel Tests for early ovarian and prostate cancer detection on the horizon

    St. Louis, MO, July 28, 2017–  Leinco Technologies, Inc. (St. Louis, MO) has officially entered into an exclusive agreement with Stage I Diagnostics (Little Rock, AR) to expand the availability of Stage I’s novel oncology blood tests for ovarian and prostate cancer.  These tests quantitatively measure the levels/expression of certain biomarkers indicating aggressive cancer causing proteins in the blood with a simple blood test. 

    “This relationship gives Stage I Diagnostics an incredible opportunity to offer early cancer diagnostics worldwide.  We know that Leinco Technologies is a leader in antibody development and distribution and we feel fortunate to partner with them.”

    Leinco Technologies, Inc. is a US biotechnology company founded in 1992 focused on assay development, and manufacturing of  antibodies, recombinant proteins, ELISA kits, and other life sciences solutions. Leinco Technologies has distribution and sales channels in the life science research, drug discovery and clinical diagnostic markets.

    “We look forward to representing Stage I Diagnostics for commercialization of their novel oncology protein biomarker assays and helping them further develop these assays for use on the gold standard  in multiplexing."

    If you would like more information about this topic, please contact Wm. Pat Leinert at 314-974-4113 or email at pleinert@leinco.com.


    Wm. Pat Leinert







 Additional Info

Included in the Export Interest Directory?
Business Needs:
Direct Sales, Distributor/Agent/Representative, Joint Ventures, Licensing Agreements
Countries of Interest:
Australia, Belgium, Brazil, Canada, Czech Republic, Denmark, Dominican Republic, Finland, France, Germany, Greece, Greenland, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Korea (South), Kuwait, Mexico, Netherlands, New Zealand, Norway, Panama, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Swaziland, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States